Doug Hampton

Novarad’s VisAR Receives FDA Clearance for Augmented Reality Surgical Navigation in Spinal Surgery in Indonesia

by

SALT LAKE CITY, May 12, 2023 /PRNewswire/ — Novarad’s VisAR, a surgical navigation system that uses augmented reality, has received clearance from Indonesia’s FDA for intraoperative use in stereotactic spinal surgery. VisAR is accurate for both open and minimally invasive surgery (MISS). This cutting-edge technology enables surgeons to transform a patient’s imaging data into a … Read more

Precision Optics Announces $1.5 Million Follow-On Product Development Order for Single Use Urology Program

by

GARDNER, Mass., May 12, 2023 /PRNewswire/ — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of a follow-on product development order for a next generation single-use urology program totaling approximately $1.5 million from an established medical device company … Read more

Kyowa Kirin Presents New Findings from Real-World Study in Parkinson’s Disease at the 2023 IAPRD Conference

by

Findings to be presented at International Association of Parkinsonism and Related Disorders (IARPD) 2023 World Congress being held May 13-16, 2023. BEDMINSTER, N.J., May 12, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, will share results from a retrospective study evaluating … Read more

Amyotrophic Lateral Sclerosis Treatment Market to Reach $1.0 Billion, Globally, by 2032 at 4.6% CAGR: Allied Market Research

by

The global amyotrophic lateral sclerosis treatment market is driven by factors such as an increase in prevalence of amyotrophic lateral sclerosis, initiatives by government and non-government organizations, and growth in awareness and understanding of ALS. PORTLAND, Ore., May 12, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Amyotrophic Lateral Sclerosis Treatment Market by … Read more

Sealonix, Inc. Closes $20 Million Financing to Develop Sealant Products for Abdominopelvic and Orthopedic Procedures

by

BEDFORD, Mass., May 12, 2023 /PRNewswire/ — Sealonix announced today that it has closed a $20 million Series A financing. The round was led by Excelestar Ventures with additional participation from AMED Ventures, Sparta Group, Iyengar Capital, J2 Ventures and TiE Boston.   Sealonix is using its biomaterials expertise to develop next generation hemostatic sealants for … Read more

Cochrane Oral Health Collaborating Center Launched at Penn Dental Medicine

by

PHILADELPHIA, May 12, 2023 /PRNewswire/ — Penn Dental Medicine’s Center for Integrative Global Oral Health (CIGOH) has partnered with Cochrane Oral Health to form the Cochrane Oral Health Collaborating Center at Penn Dental Medicine. The new Center marks a significant step in helping to expand evidence-based knowledge to inform practice and oral health policy worldwide. Cochrane Oral Health, at The … Read more

Available Now – New EmuaidMAX® Concentrate Serum an Enhanced Version of Top-Selling EmuaidMAX® First Aid Ointment

by

FORT LAUDERDALE, Fla., May 12, 2023 /PRNewswire/ — Speer Laboratories announces the launch of a new serum version of their top-selling skin ointment EmuaidMAX®, a homeopathic first aid treatment that has disrupted the first aid category by providing a highly effective, natural, multipurpose solution that treats symptoms of over 100 skin and nail conditions. Unlike … Read more

Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update

by

Patient dosing initiated for Phase 2b study of PUR1900 for ABPA Phase 1 study of PUR3100 for migraine achieves positive topline results $30.8 million in cash and cash equivalents at the end of Q1 2023 providing projected cash runway into Q4 2024 LEXINGTON, Mass., May 12, 2023 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company … Read more

BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

by

MINNEAPOLIS, May 12, 2023 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 2:35 p.m. EDT. A live webcast of the presentation can be accessed via the IR Calendar … Read more